HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effects of N-acetylcysteine on hypothermic ischemia-reperfusion injury of rat liver.

Abstract
We investigated whether intraportal injection of 150 mg/kg N-acetylcysteine (NAC) into rats reduced hepatic ischemia-reperfusion injury after 48 hours of cold storage and 2 hours of reperfusion. The organ was isolated and perfused to evaluate liver function. The control group received an intraportal injection of 5% dextrose. NAC increased L-cysteine concentrations 15 minutes after injection (1.29 +/- 0.11 mumol/g vs. 2.68 +/- 0.4 mumol/g, P < .05). However, neither treatment modified glutathione liver concentrations relative to preinjection values. After 48 hours of cold storage and 2 hours of reperfusion, livers from NAC-treated rats produced larger amounts of bile than those in the control group (5.04 +/- 1.92 vs. 0.72 +/- 0.37 microL/g liver; P < .05), and showed a significant reduction in liver injury, as indicated by reduced release of lactate dehydrogenase (679.4 +/- 174.4 vs. 1891.3 +/- 268.3 IU/L/g; P < .01), aspartate transaminase (AST) (13.94 +/- 3.5 vs. 38.75 IU/L/g; P < .01), alanine transaminase ALT) (14.92 +/- 4.09 vs. 45.91 +/- 10.58 IU/L/g; P < .05), and acid phosphatase, a marker of Kupffer cell injury (344.4 +/- 89.6 vs. 927.3 +/- 150.8 IU/L/g; P < .01) in the perfusate. Reduced glutathione concentrations in the perfusate were similar in the two groups (805 +/- 69 vs. 798 +/- 252 nmol/L/g), whereas oxidized glutathione (GSSG) concentrations were higher in the control group (967 +/- 137 vs. 525 +/- 126 nmol/L/g; P < .05). Reduced glutathione (GSH) concentrations in liver tissue collected at the end of perfusion were significantly higher in the NAC group (7.3 +/- 0.9 vs. 4.1 +/- 1.0 mumol/g; P < .05).(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsH Nakano, K Boudjema, E Alexandre, P Imbs, M P Chenard, P Wolf, J Cinqualbre, D Jaeck
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 22 Issue 2 Pg. 539-45 (Aug 1995) ISSN: 0270-9139 [Print] United States
PMID7635422 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Methionine Sulfoximine
  • Buthionine Sulfoximine
  • L-Lactate Dehydrogenase
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Acid Phosphatase
  • Glutathione
  • Cysteine
  • Acetylcysteine
Topics
  • Acetylcysteine (administration & dosage, therapeutic use)
  • Acid Phosphatase (metabolism)
  • Alanine Transaminase (metabolism)
  • Animals
  • Aspartate Aminotransferases (metabolism)
  • Buthionine Sulfoximine
  • Cold Temperature
  • Cysteine (metabolism)
  • Glutathione (metabolism)
  • L-Lactate Dehydrogenase (metabolism)
  • Liver (blood supply, metabolism)
  • Male
  • Methionine Sulfoximine (analogs & derivatives, pharmacology)
  • Oxidation-Reduction
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: